Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR

Journal of Veterinary Diagnostic Investigation

Volumn 17, Issue 6, 2005, Pages 578-581

  Pusterla, Nicola ^a   Leutenegger, Christian M ^a   Wilson, W David ^a   Watson, Johanna L ^a   Ferraro, Gregory L ^a   Madigan, John E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Equine herpesvirus 4; Nasopharyngeal secretions; Peripheral blood leukocytes; TaqMan PCR

Indexed keywords

EQUINE HERPESVIRUS 4; HERPESVIRIDAE;

EID: 27944431661     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870501700610     Document Type: Article

References (17)

1. Alvira MR, Goins WF, Cohen JB, et al.: 1999, Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. J Virol 73:3866-3876.
2. Borchers K, Slater J: 1993, A nested PCR for the detection and differentiation of EHV-1 and EHV-4. J Virol Methods 45:331-336.
3. Borchers K, Wolfinger U, Lawrenz B, et al.: 1997, Equine herpesvirus 4 DNA in trigeminal ganglia of naturally infected horses detected by direct in situ PCR. J Gen Virol 78:1109-1114.
4. Carvalho LM, Passos F, Martins AS: 2000, Development of a differential multiplex PCR assay for equine herpesvirus 1 and 4 as a diagnostic tool. J Vet Med B 47:351-359.
5. Crabb BS, Studdert MJ: 1995, Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv Virus Res 45:153-190.
6. Fitzpatrick DR, Studdert MJ: 1984, Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus). Am J Vet Res 45:1947-1952.
7. Heldens JG, Hannant D, Cullinane AA, et al.: 2001, Clinical and virological evaluation of the efficacy of an inactivated EHV-1 and EHV-4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 19:4307-4317.
8. Jones C: 1998, Alphaherpesvirus latency: its role in disease and survival of the virus in nature. Adv Virus Res 51:81-133.
9. Kaye SB, Lynas C. Patterson A, et al.: 1991, Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol 75:195-200.
10. Lawrence GL, Gilkerson J, Love DN, et al.: 1994, Rapid, single-step differentiation of equid herpesviruses 1 and 4 from clinical material using the polymerase chain reaction and virus-specific primers. J Virol Methods 47:59-72.
11. Leutenegger CM, von Rechenberg B, Huder JB, et al.: 1999, Quantitative real-time PCR for equine cytokine mRNA in non-decalcified bone tissue embedded in methyl methacrylate. Calcif Tissue Int 65:378-383.
12. Patel JR, Földi J, Bateman H, et al.: 2003, Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Vet Microbiol 92:1-17.
13. Sharma PC, Cullinane AA, Onions DE, et al.: 1992, Diagnosis of equid herpesviruses-1 and -4 by polymerase chain reaction. Equine Vet J 24:20-25.
14. Tewari D, Gibson JS, Slater JD, et al.: 1993, Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1. Arch Virol 132:101-120.
15. Varrasso A, Dynon K, Ficorilli N, et al.: 2001, Identification of equine herpesviruses 1 and 4 by polymerase chain reaction. Aust Vet J 79:563-569.
16. Wagner WN, Bogdan J, Haines D: 1992, Detection of equine herpesvirus and differentiation of equine herpesvirus type 1 from type 4 by the polymerase chain reaction. Can J Microbiol 38:1193-1196.
17. Welch HM, Bridges CG, Lyon AM, et al.: 1992, Latent equine herpesvirus-1 and -4 detection and distinction using the PCR and co-cultivation from lymphoid tissue. J Gen Virol 73:261-268.